The following paragraph is copied and pasted from Dr Rath's newsletter.
A ruckus erupted last year when reports surfaced that Glaxo was accused of intimidating John Buse, a University of North Carolina researcher who, years earlier, questioned the safety of its Avandia diabetes pill, which was linked to heart problems (back story). However, he wasn’t the only one the drugmaker tried to stifle. A doctor from a small Maryland hospital linked Avandia to congestive heart failure in 2000, but Glaxo rejected her warning and tried stop her from talking about it with other docs and hospitals, The Wall Street Journal reports.
Read article at pharmalot.com